GlassScriptPhysician profile
Kenneth Etra
NPI 1225012313
$2,581.79
in general payments reported to CMS, 2019-2025
17 companies · $851 in 2025
The $851 reported for 2025 was more than what 76% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $11.20 · 2021: $237 · 2022: $300 · 2023: $810 · 2024: $253 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,914.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $740.04 | 2021-2025 | |
| Glaxosmithkline, LLC. | $266.62 | 2021-2025 | Nucala |
| Astrazeneca Pharmaceuticals LP | $245.02 | 2025 | Airsupra, Breztri |
| Phathom Pharmaceuticals, INC. | $197.64 | 2024-2025 | Voquezna |
| Regeneron Healthcare Solutions, INC. | $178.69 | 2019-2025 | Dupixent |
| Inspire Medical Systems, INC. | $154.88 | 2023 | Inspire |
| Genzyme Corporation | $128.42 | 2021-2025 | |
| Acclarent, INC | $112.50 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $86.22 | 2020-2023 | |
| Kaleo, INC. | $80.46 | 2019-2023 | Auvi-Q |
| Grifols USA, LLC | $76.45 | 2023-2025 | Xembify |
| Octapharma USA, INC. | $67.21 | 2024-2025 | Panzyga, Cutaquig |
| Hikma Pharmaceuticals USA | $59.10 | 2023-2025 | Ryaltris |
| Novartis Pharmaceuticals Corporation | $57.58 | 2025 | |
| Abbvie INC. | $53.50 | 2021-2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharming Healthcare, INC. | $50.50 | 2023-2025 | Ruconest |
| Pfizer INC. | $26.96 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Etra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.